Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrin
Source abstract
Abstract
The aim of this study was to evaluate the physical-chemical properties, in vivo biocompatibility and antimicrobial activity of bioactive glasses (BG) used as a controlled release device for tetracycline hydrochloride and an inclusion complex formed by tetracycline and beta-cyclodextrin at 1:1 molar ratio. The BG as well as their compounds loaded with tetracycline (BT) and tetracycline:beta-cyclodextrin (BTC) were characterized by FTIR spectroscopy, X-ray powder diffraction, differential scanning calorimetry and by scanning electron microscopy and energy dispersive spectroscopy. The in vivo test was carried out with female mice split into three groups treated with bioactive glass either without drugs, or associated with tetracycline, or with tetracycline:beta-cyclodextrin by subcutaneous implantation. The histological examination of tissue at the site of implantation showed moderate inflammatory reactions in all groups after 72 h. The bacterial effect was tested on A. actinomycetemcomitans suspended in BHI broth, with or without bioactive particles. A considerable bacteriostatic activity was found with BT and BTC glasses, as compared to plain glass. The presence of cyclodextrin was important to slow down the release of tetracycline for a long period of time and it was verified that the presence of tetracycline or its inclusion complex, tetracycline:beta-cyclodextrin, did not affect the bioactivity of the glass.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthodontics and Dentofacial Orthopedics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (26)
Show source-provided references
1. The fate of autogenous and homogenous bone grafts
2. Saito K, Hoshino T. Apatite-coated solid composition. US Patent 6344209, 2002.
3. Bioactive materials10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F ↗
4. Biomaterials; a forecast for the future10.1016/S0142-9612(98)00133-1 ↗
5. In vivo comparison of bioactive glass particles in rabbits10.1016/S0142-9612(00)00191-5 ↗
6. Bioabsorbable scaffolds for guided bone, regeneration and generation10.1016/S0142-9612(00)00117-4 ↗
7. Histological comparison of healing extraction sockets implanted with bioactive glass or demineralized freeze-dried bone allograft10.1902/jop.2002.73.1.94 ↗
8. Bioactive sol–gel foams for tissue repair10.1002/jbm.1250 ↗
9. Biomaterial developments for bone tissue engineering10.1016/S0142-9612(00)00102-2 ↗
10. A biochemical approach to periodontal regeneration10.1111/j.1600-0765.1986.tb01466.x ↗
11. The use of tetracycline—containing controlled—release fibers in the treatment of refractory periodontitis10.1902/jop.1997.68.4.353 ↗
12. Multicenter evaluation of tetracycline fiber therapy II. Clinical response10.1111/j.1600-0765.1991.tb02076.x ↗
13. Tetracyclines in the management of periodontal diseases10.1111/j.1600-051X.1995.tb01767.x ↗
14. A six-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients10.1902/jop.1994.65.7.685 ↗
15. Szejtli J. Cyclodextrin technology. Netherlands: Kluwer; 1988. p. 1–170.10.1007/978-94-015-7797-7_1 ↗
16. Preparation and characterization of the inclusion compound between Rhodium (II) α cynamate10.1007/BF00707684 ↗
17. Szejtli J, Osa T, editors. Chemistry, physical and biological properties of cyclodextrins. In: Comprehensive supramolecular chemistry, vol. 3 (Cyclodextrins). Oxford: Pergamon; 1996. p. 5–40 [Chapter 2].
18. Cyclodextrin drug carrier systems10.1021/cr970025p ↗
19. Industrial applications of cyclodextrins10.1021/cr970014w ↗
20. Pharmaceutical applications of cyclodextrins. III. Toxicological and safety evaluation10.1021/js960213f ↗
21. Controlled release of rhodium(II) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix10.1016/S0142-9612(01)00386-6 ↗
22. A sol–gel derived bioactive fibrous mesh10.1002/1097-4636(20010615)55:4<468::AID-JBM1038>3.0.CO;2-T ↗
23. Surface effects and desorption of tetracycline supramolecular complex on bovine dentine10.1016/S0142-9612(02)00403-9 ↗
24. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W10.1002/jbm.820240607 ↗
25. Cortés ME, Sinisterra RD, Alves de Carvalho CA. Preparation and characterization of tetracycline hydrochloride:β-cyclodextrin. CD ROM 10th International Cyclodextrin Symposium, CD2000, Ann Arbor, MI, USA, 090, p. 1–5.
26. Antibacterial activity of particulate Bioglass® against supra- and subgingival bacteria10.1016/S0142-9612(00)00330-6 ↗